The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Luciano Juan R | Director | Grant(A) | 14 | $1,129.35 | $16K |
| Jun 15, 2026 | Sulzberger Gabrielle | Director | Grant(A) | 4 | $1,129.35 | $5K |
| Jun 15, 2026 | Alvarez Ralph | Director | Grant(A) | 11 | $1,129.35 | $12K |
| Jun 15, 2026 | Fyrwald J Erik | Director | Grant(A) | 9 | $1,129.35 | $10K |
| Jun 10, 2026 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Sell(S) | 3K | $1,150.77 | $2.9M |
| May 18, 2026 | Sulzberger Gabrielle | Director | Grant(A) | 5 | $988.09 | $5K |
| May 18, 2026 | Luciano Juan R | Director | Grant(A) | 16 | $988.09 | $16K |
| May 18, 2026 | Fyrwald J Erik | Director | Grant(A) | 10 | $988.09 | $10K |
| May 18, 2026 | Alvarez Ralph | Director | Grant(A) | 13 | $988.09 | $12K |
| May 6, 2026 | Lilly Endowment Inc | Insider | Sell(S) | 14K | $995.23 | $13.6M |
| May 6, 2026 | Lilly Endowment Inc | Insider | Sell(S) | 2K | $996.18 | $2.2M |
| Apr 20, 2026 | Sulzberger Gabrielle | Director | Grant(A) | 5 | $919.90 | $5K |
| Apr 20, 2026 | Luciano Juan R | Director | Grant(A) | 17 | $919.90 | $16K |
| Apr 20, 2026 | Fyrwald J Erik | Director | Grant(A) | 11 | $919.90 | $10K |
| Apr 20, 2026 | Alvarez Ralph | Director | Grant(A) | 13 | $919.90 | $12K |
| Mar 16, 2026 | Sulzberger Gabrielle | Director | Grant(A) | 5 | $989.12 | $5K |
| Mar 16, 2026 | Luciano Juan R | Director | Grant(A) | 16 | $989.12 | $16K |
| Mar 16, 2026 | Fyrwald J Erik | Director | Grant(A) | 10 | $989.12 | $10K |
| Mar 16, 2026 | Alvarez Ralph | Director | Grant(A) | 13 | $989.12 | $12K |
| Feb 19, 2026 | Dozier Eric | EVP, Chief People Officer | Gift(G) | 481 | — | $0 |
| Feb 17, 2026 | Sulzberger Gabrielle | Director | Grant(A) | 5 | $1,036.05 | $5K |
| Feb 17, 2026 | Luciano Juan R | Director | Grant(A) | 15 | $1,036.05 | $16K |
| Feb 17, 2026 | Fyrwald J Erik | Director | Grant(A) | 10 | $1,036.05 | $10K |
| Feb 17, 2026 | Alvarez Ralph | Director | Grant(A) | 12 | $1,036.05 | $12K |
| Feb 16, 2026 | Zakrowski Donald A | SVP, Finance, & CAO | Option exercise(M) | 184 | — | $0 |
| Feb 16, 2026 | Zakrowski Donald A | SVP, Finance, & CAO | Tax withholding(F) | 82 | $1,040.00 | $85K |
| Feb 16, 2026 | Zakrowski Donald A | SVP, Finance, & CAO | Option exercise(M) | 184 | — | $0 |
| Feb 16, 2026 | Montarce Lucas | EVP & CFO | Option exercise(M) | 368 | — | $0 |
| Feb 16, 2026 | Montarce Lucas | EVP & CFO | Tax withholding(F) | 160 | $1,040.00 | $166K |
| Feb 16, 2026 | Montarce Lucas | EVP & CFO | Option exercise(M) | 368 | — | $0 |
| Feb 16, 2026 | Custer Kenneth L. | EVP & President, Card Met Hlth | Option exercise(M) | 207 | — | $0 |
| Feb 16, 2026 | Custer Kenneth L. | EVP & President, Card Met Hlth | Tax withholding(F) | 91 | $1,040.00 | $95K |
| Feb 16, 2026 | Custer Kenneth L. | EVP & President, Card Met Hlth | Option exercise(M) | 207 | — | $0 |
| Feb 16, 2026 | Brown Adrienne S | EVP, President LLY Imm | Option exercise(M) | 391 | — | $0 |
| Feb 16, 2026 | Brown Adrienne S | EVP, President LLY Imm | Tax withholding(F) | 170 | $1,040.00 | $177K |
| Feb 16, 2026 | Brown Adrienne S | EVP, President LLY Imm | Option exercise(M) | 391 | — | $0 |
| Feb 9, 2026 | Zakrowski Donald A | SVP, Finance, & CAO | Grant(A) | 584 | $1,044.67 | $610K |
| Feb 9, 2026 | Zakrowski Donald A | SVP, Finance, & CAO | Grant(A) | 199 | — | $0 |
| Feb 9, 2026 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Grant(A) | 4K | $1,044.67 | $4.3M |
| Feb 9, 2026 | Van Naarden Jacob | EVP,Pres LLY Oncology&HdCorpBD | Grant(A) | 5K | $1,044.67 | $5.1M |
| Feb 9, 2026 | Skovronsky Daniel | EVP, CS&PO & Pres. LRL | Grant(A) | 16K | $1,044.67 | $16.2M |
| Feb 9, 2026 | Ricks David A | President, Chair, and CEO, Director | Grant(A) | 39K | $1,044.67 | $40.7M |
| Feb 9, 2026 | Montarce Lucas | EVP & CFO | Grant(A) | 1K | $1,044.67 | $1.4M |
| Feb 9, 2026 | Jonsson Patrik | EVP & President, LLY Int'l | Grant(A) | 5K | $1,044.67 | $5.0M |
| Feb 9, 2026 | Hernandez Edgardo | EVP & Pres., Mfg. Operations | Grant(A) | 4K | $1,044.67 | $4.6M |
| Feb 9, 2026 | Hakim Anat | EVP, GC & Secretary | Grant(A) | 8K | $1,044.67 | $8.6M |
| Feb 9, 2026 | Dozier Eric | EVP, Chief People Officer | Grant(A) | 4K | $1,044.67 | $3.7M |
| Feb 9, 2026 | Custer Kenneth L. | EVP & President, Card Met Hlth | Grant(A) | 659 | $1,044.67 | $689K |
| Feb 9, 2026 | Brown Adrienne S | EVP, President LLY Imm | Grant(A) | 1K | $1,044.67 | $1.2M |
| Feb 9, 2026 | Rau Diogo | EVP & CIDO | Grant(A) | 5K | $1,044.67 | $4.8M |
| Feb 1, 2026 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Option exercise(M) | 3K | — | $0 |
| Feb 1, 2026 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Tax withholding(F) | 2K | $1,037.15 | $1.6M |
| Feb 1, 2026 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Option exercise(M) | 3K | — | $0 |
| Feb 1, 2026 | Skovronsky Daniel | EVP, CS&PO & Pres. LRL | Option exercise(M) | 13K | — | $0 |
| Feb 1, 2026 | Skovronsky Daniel | EVP, CS&PO & Pres. LRL | Tax withholding(F) | 6K | $1,037.15 | $5.9M |
| Feb 1, 2026 | Skovronsky Daniel | EVP, CS&PO & Pres. LRL | Option exercise(M) | 13K | — | $0 |
| Feb 1, 2026 | Van Naarden Jacob | EVP,Pres LLY Oncology&HdCorpBD | Option exercise(M) | 4K | — | $0 |
| Feb 1, 2026 | Van Naarden Jacob | EVP,Pres LLY Oncology&HdCorpBD | Tax withholding(F) | 2K | $1,037.15 | $2.0M |
| Feb 1, 2026 | Van Naarden Jacob | EVP,Pres LLY Oncology&HdCorpBD | Option exercise(M) | 4K | — | $0 |
| Feb 1, 2026 | Ricks David A | President, Chair, and CEO, Director | Option exercise(M) | 32K | — | $0 |
| Feb 1, 2026 | Ricks David A | President, Chair, and CEO, Director | Tax withholding(F) | 14K | $1,037.15 | $14.8M |
| Feb 1, 2026 | Ricks David A | President, Chair, and CEO, Director | Option exercise(M) | 32K | — | $0 |
| Feb 1, 2026 | Rau Diogo | EVP & CIDO | Option exercise(M) | 4K | — | $0 |
| Feb 1, 2026 | Rau Diogo | EVP & CIDO | Tax withholding(F) | 2K | $1,037.15 | $1.7M |
| Feb 1, 2026 | Rau Diogo | EVP & CIDO | Option exercise(M) | 4K | — | $0 |
| Feb 1, 2026 | Jonsson Patrik | EVP & President, LLY Int'l | Option exercise(M) | 4K | — | $0 |
| Feb 1, 2026 | Jonsson Patrik | EVP & President, LLY Int'l | Tax withholding(F) | 2K | $1,037.15 | $1.8M |
| Feb 1, 2026 | Jonsson Patrik | EVP & President, LLY Int'l | Option exercise(M) | 4K | — | $0 |
| Feb 1, 2026 | Hernandez Edgardo | EVP & Pres., Mfg. Operations | Option exercise(M) | 4K | — | $0 |
| Feb 1, 2026 | Hernandez Edgardo | EVP & Pres., Mfg. Operations | Tax withholding(F) | 2K | $1,037.15 | $1.7M |
| Feb 1, 2026 | Hernandez Edgardo | EVP & Pres., Mfg. Operations | Option exercise(M) | 4K | — | $0 |
| Feb 1, 2026 | Hakim Anat | EVP, GC & Secretary | Option exercise(M) | 7K | — | $0 |
| Feb 1, 2026 | Hakim Anat | EVP, GC & Secretary | Tax withholding(F) | 3K | $1,037.15 | $3.1M |
| Feb 1, 2026 | Hakim Anat | EVP, GC & Secretary | Option exercise(M) | 7K | — | $0 |
| Feb 1, 2026 | Dozier Eric | EVP, Chief People Officer | Option exercise(M) | 3K | — | $0 |
| Feb 1, 2026 | Dozier Eric | EVP, Chief People Officer | Tax withholding(F) | 1K | $1,037.15 | $1.3M |
| Feb 1, 2026 | Dozier Eric | EVP, Chief People Officer | Option exercise(M) | 3K | — | $0 |
| Jan 20, 2026 | Sulzberger Gabrielle | Director | Grant(A) | 5 | $1,041.29 | $5K |
| Jan 20, 2026 | Luciano Juan R | Director | Grant(A) | 15 | $1,041.29 | $16K |
| Jan 20, 2026 | Fyrwald J Erik | Director | Grant(A) | 10 | $1,041.29 | $10K |
| Jan 20, 2026 | Alvarez Ralph | Director | Grant(A) | 12 | $1,041.29 | $12K |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 895 | $1,085.11 | $971K |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 8K | $1,086.75 | $8.4M |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 1K | $1,087.80 | $1.2M |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 930 | $1,088.97 | $1.0M |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 4K | $1,090.18 | $3.9M |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 1K | $1,091.05 | $1.3M |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 1K | $1,092.56 | $1.2M |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 1K | $1,093.58 | $1.4M |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 420 | $1,094.70 | $460K |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 475 | $1,095.74 | $520K |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 6K | $1,097.41 | $7.0M |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 10K | $1,098.55 | $10.5M |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 20K | $1,099.36 | $22.5M |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 15K | $1,100.46 | $16.4M |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 21K | $1,101.42 | $22.8M |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 34K | $1,102.41 | $38.0M |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 41K | $1,103.31 | $45.2M |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 21K | $1,104.40 | $23.2M |
| Jan 7, 2026 | Lilly Endowment Inc | 10% Owner | Sell(S) | 24K | $1,105.46 | $26.9M |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-18. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).